S2107 Adoptive immunotherapy
S-Codes
Also known as: cellular immunotherapy, CAR-T cell therapy
Adoptive immunotherapy. Infusion of patient-derived modified immune cells for cancer treatment.
Clinical Context
Infusion of genetically modified T-lymphocytes (CAR-T cells) or other immune cells targeting cancer cells. Requires careful monitoring for cytokine release syndrome.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.